97560305 - FINLIBDY

Information

• Trademark
• 97560305

• Source

• Serial Number

  97560305

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 23, 2022
  3 years ago

• Transaction Date

  May 29, 2025
  7 months ago

• Status Date

  May 27, 2025
  8 months ago

• Published for Opposition Date

  October 10, 2023
  2 years ago

• Location Date

  February 14, 2025
  11 months ago

• Status Code

  732

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CALLAGHAN, BRIAN

• Attorney Docket Number

  214705020100

  Attorney Name

  Palak Mayani

  Law Office Assigned Location Code

  L80

• Owners

  • Prometheus Biosciences, Inc.

Case File Statements

• GS0051: Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer
• GS0011: Diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use
• GS0441: Health care services, namely, disease management programs; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to medical treatment recommendation; medical consultation; providing a website featuring information about medical services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; medical diagnostic testing provided by medical laboratories; medical analysis services in the nature of laboratory testing for disease management and patient diagnosis and patient selection for the diagnosis and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, provided by medical laboratories; medical analysis services relating to the treatment of patients in the nature of laboratory testing for the purpose of immune modulation and management of side effects associated with renal disorders and cancer, provided by medical laboratories
• GS0421: Medical laboratory services, namely, laboratory testing for scientific research purposes and medical research services; medical laboratory services, namely, laboratory testing for scientific research purposes in the field of disease management and gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; medical laboratory services, namely, laboratory testing for scientific research of immune modulation and management of side effects associated with renal disorders and cancer pathology; medical laboratory services, namely, laboratory testing for scientific research of patient disease diagnoses and for patient selection for clinical trials

Case File Event Statements

• 4/3/2023 - 2 years ago

  4 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/26/2022 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/12/2022 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/3/2023 - 2 years ago

  3 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/3/2023 - 2 years ago

  5 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/9/2023 - 2 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 6/13/2023 - 2 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/13/2023 - 2 years ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/13/2023 - 2 years ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/23/2023 - 2 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/23/2023 - 2 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/24/2023 - 2 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/6/2023 - 2 years ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/6/2023 - 2 years ago

  14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/6/2023 - 2 years ago

  15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/6/2023 - 2 years ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/6/2023 - 2 years ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/10/2023 - 2 years ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/20/2023 - 2 years ago

  18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/10/2023 - 2 years ago

  20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/13/2024 - a year ago

  24 - SOU EXTENSION 1 GRANTED Type: EX1G

• 12/5/2023 - 2 years ago

  21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/13/2024 - a year ago

  22 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/13/2024 - a year ago

  23 - SOU EXTENSION 1 FILED Type: EXT1

• 5/14/2024 - a year ago

  25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 11/11/2024 - a year ago

  27 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 11/11/2024 - a year ago

  26 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 11/11/2024 - a year ago

  28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 11/11/2024 - a year ago

  29 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 11/19/2024 - a year ago

  30 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/13/2025 - a year ago

  36 - SOU EXTENSION 2 FILED Type: EXT2

• 1/13/2025 - a year ago

  31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/13/2025 - a year ago

  32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 1/13/2025 - a year ago

  33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/14/2025 - 11 months ago

  37 - SOU EXTENSION 2 GRANTED Type: EX2G

• 2/15/2025 - 11 months ago

  35 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 1/13/2025 - a year ago

  34 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 5/27/2025 - 8 months ago

  39 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/27/2025 - 8 months ago

  40 - SOU EXTENSION 3 FILED Type: EXT3

• 5/27/2025 - 8 months ago

  41 - SOU EXTENSION 3 GRANTED Type: EX3G

• 2/15/2025 - 11 months ago

  38 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA